DGAP-News: EasyMotionSkin Tec AG
/ Key word(s): IPO
EasyMotionSkin – sucessful stock market debut
10.12.2021 / 08:05
The issuer is solely responsible for the content of this announcement.
THE INFORMATION CONTAINED IN THIS DOCUMENT IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION, NEITHER IN WHOLE NOR IN PART, TO, WITHIN OR FROM THE UNITED STATES OF AMERICA OR ANY OTHER COUNTRY WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH COUNTRY.
EasyMotionSkin Tec AG celebrates their successful stock market debut
– Listing in the m:access trading segment of the Munich Stock Exchange has taken place
– Public offering of a total of 10,000 shares fully placed
– Leading provider of innovative EMS training systems
– Sales activities to be expanded
Vaduz/Triesen, December 10, 2021. EasyMotionSkin Tec AG (EasyMotionSkin), a leading provider in the market of training and fitness systems using electromuscular stimulation (EMS), enriches the stock exchange list of the Munich Stock Exchange as of today. The share (ISIN: LI1147158318) started trading today at a price of EUR 14,50 in the m:access trading segment, corresponding to an initial market capitalization of EUR 145 million. In connection with the listing, a total of 10,000 EasyMotionSkin shares were successfully placed during a public offering. All 10,000,000 ordinary bearer shares of EasyMotionSkin were included into the over-the-counter market.
Together with its subsidiaries, the company produces and distributes EMS training systems consisting of a suit, PowerBox and an app solution for various training programs. The EasyMotionSkin systems have distinct advantages over conventional EMS training equipment: Firstly, the patented dry electrode in the suit sets new standards in wearing comfort. Secondly, they work wirelessly – an innovation that enables flexible use. Users are no longer tied exclusively to studios; they can train independently of time and space. Thus, EasyMotionSkin is operating in a promising market environment even in times of the COVID 19 pandemic, as the EMS systems can be used both in studios and at home and, if desired, combined with digital training offers.
“With our innovative technology we are setting new standards. We are convinced that we will quickly gain market share. Our EasyMotionSkin system is an absolute premium product – developed and produced in Germany, offering many advantages and consistently leveraging digitalization. Public interest through the stock exchange listing will additionally support our growing awareness”, explains Jürgen Baltes, CEO of EasyMotionSkin Tec AG.
The securities prospectus is available for download on the issuer’s homepage (www.ems.ag) under the heading “Public Offer”. In addition, the information below (“Disclaimer”) must be observed.
About EasyMotionSkin Tec AG:
EasyMotionSkin Tec AG is the parent company of the global operating EasyMotionSkin group. As the “smallest fitness studio in the world”, EasyMotionSkin offers beginners and
athletes a sophisticated EMS training system. Patented dry electrodes in an EMS suit
stimulate up to 90% of the body’s muscles with low-frequency electrical impulses and thus
ensure increased oxygen intake, increased performance, optimal training effects and
regeneration. The basis for this trademarked high-tech product is the know-how of a leading
cardiac medic from Germany as well as acknowledged patient studies that verifiably prove
the positive effects. EasyMotionSkin is a premium product, developed and produced in
Germany. The core market is currently the DACH-region. Initial sales concepts exist in selected third countries. By using digitization and developing further product innovations, EasyMotionSkin Tec AG
spans the curve from an innovative fitness system manufacturer to a future-oriented tech
company in the international health and lifestyle industry.
Jürgen Baltes (CEO)
mail: [email protected]
According to the Regulation (EU) 2017/1129 (“Prospectus Regulation”)” and Delegated Regulation (EU) 2019/979 this publication and the contained information constitute advertising and do not represent an offer. In particular, it does not constitute a public offer to sell or an offer, or a solicitation of an offer, to acquire, purchase or subscribe for shares or any other securities. The securities prospectus approved by the German Federal Financial Supervisory Authority (BaFin) on 2 December 2021 was published on EasyMotionSkin Tec AG’s website (www.ems.ag) in the “Public Offer” section.
Investors are recommended to carefully read the securities prospectus, which has been reviewed for completeness, coherence and comprehensibility by the German Federal Financial Supervisory Authority (BaFin) which is available on EasyMotionSkin Tec AG’s website (www.ems.ag) in the “Public Offer” section, before deciding to purchase or sell shares in EasyMotionSkin Tec AG in order to fully understand the potential risks and opportunities of the investment decision, and to make an investment decision only on the basis of all available information about the company after consulting their own lawyers, tax advisors and/or financial advisors. It is noted that an approval of the securities prospectus by BaFin is not to be construed as an endorsement of the relevant securities.
The securities mentioned in this publication are, and will be, registered neither under the U.S. Securities Act of 1933 (the “Securities Act”) nor with any securities regulatory authority of any individual states of the United States of America. Unless a registration has been obtained, or exemptions from the registration requirements apply, under the U.S. Securities Act or the laws of an individual state of the United States of America, or relating to a transaction not subject to the U.S. Securities Act and in any event in accordance with the relevant laws of the individual states of the United States of America, the securities mentioned in this publication must not be (neither directly nor indirectly) offered, exercised, sold, pledged, transferred, or delivered within or to the United States of America or to, or on behalf of, or to the benefit of, a U.S. person (as defined in Regulation S under the Securities Act).
This publication may contain future-oriented statements. Future-oriented statements are all statements that do not refer to historical facts or events. This applies in particular to statements about the intentions, beliefs or current expectations of the company with respect to its future financial performance, plans, liquidity, prospects, growth, strategy and profitability as well as the economic environment in which the company operates. The future-oriented statements are based on current assessments and assumptions made by the company to the best of its knowledge. However, such future-oriented statements are subject to risks and uncertainties because they relate to future events and are based on assumptions that may not occur in the future. The company is not obligated to update or modify the future-oriented statements contained in this publication to reflect events or circumstances occurring after the date of this publication, unless such events or circumstances constitute an insider information subject to publication requirements.
10.12.2021 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort